MedTrace Logo

Quality of Life and Sexual Function of the Novasure Endometrial Ablation in Menorrhagia

NCT01910584 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2013-07-29

No results posted yet for this study

Summary

The aim of this study is to investigate the influence on the quality of life and sexual function before, 6 month and one year after Novasure Endometrial Ablation in the treatment of Menorrhagia.

Conditions

  • Quality of Life
  • Sexual Activity

Interventions

PROCEDURE

Novasure endometrial ablation

Novasure endometrial ablation is the second generation endometrial ablation treatment aimed to cure the dysfunctional uterine bleeding(DUB),including menorrhagia.

Sponsors & Collaborators

  • Shu-Qin Chen

    lead OTHER

Principal Investigators

  • Shu-Zhong Yao, PhD & MD · First Affiliated Hospital, Sun Yat-Sen University

Eligibility

Min Age
25 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-11-30
Primary Completion
2015-11-30
Completion
2015-11-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01910584 on ClinicalTrials.gov